Dusigitumab
Istiratumab
Dalotuzumab
Ganitumab
Teprotumumab
Xentuzumab
Robatumumab
Figitumumab
Cixutumumab
Veligrotug
IGF-I (30-41) (TFA)
IGF-I (24-41) (TFA)
IGF-I (24-41)
Chimaphilin
Ginsenoside Rg5 (Standard)
Ginsenoside Rg5
Sorbic acid
AZ7550
AZ7550 Mesylate
AZ7550-d 5